Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “MENS”

99 pharma patents match "MENS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 99
Index total 30,257
Page 1 / 5

Quick answer

This filtered view shows 99 pharmaceutical patents matching "MENS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

99 results for “MENS” · 30,257 patents in full index Clear search

  1. US 12390463

    Dosage forms and regimens for amino acid compounds

    Pliant Therapeutics, Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 12370181

    Regimens of estrogen receptor antagonists

    Olema Pharmaceuticals, Inc. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted
  3. US 12364683

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12290566

    Dosing regimens and related compositions and methods

    Apellis Pharmaceuticals, Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  5. US 12213989

    Use of maribavir in treatment regimens

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  6. US 12181555

    3-dimensional representations of post-contrast enhanced brain lesions

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  7. US 12138247

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  8. US 12109196

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  9. US 12090140

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  10. US 11998529

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  11. US 11998528

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  12. US 11957684

    Treatment of heavy menstrual bleeding associated with uterine fibroids

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  13. US 11903994

    Dosing regimens

    Apellis Pharmaceuticals, Inc. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  14. US 11890272

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  15. US 11885861

    3-dimensional representations of post-contrast enhanced brain lesions

    The Board of Regents of the University of Texas System · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  16. US 11857697

    Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  17. US 11844841

    Dosing regimens and related compositions and methods

    Apellis Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  18. US 11839611

    Buprenorphine dosing regimens

    Indivior UK Limited · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  19. US 11806334

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  20. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  21. EP 4125971

    BAKTERIENSTÄMME, ZUSAMMENSETZUNGEN DAVON UND VERWENDUNG DAVON IN EINEM VERFAHREN ZUR BEHANDLUNG VON VITAMIN-D-MANGEL UND DAMIT ASSOZIIERTEN ERKRANKUNGEN

    SOFAR SPA [IT] · Granted Feb 8, 2023 · Expires Feb 3, 2043

    granted
  22. US 11419869

    Dosage forms and regimens for amino acid compounds

    Pliant Therapeutics, Inc. · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  23. EP 4031157

    BAKTERIENSTÄMME, IHRE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG ZUR BEHANDLUNG GASTROINTESTINALER ERKRANKUNGEN

    SOFAR SPA [IT] · Granted Jul 27, 2022 · Expires Jul 22, 2042

    granted
  24. US 11345894

    Cellular seeding and co-culture of a three dimensional fibroblast construct

    United States Government as represented by the Department of Veterans Affairs · Granted May 31, 2022 · Expires May 26, 2042

    granted